Literature DB >> 7622414

Formation and removal of DNA adducts in the liver of rats chronically fed the food-borne carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.

M Hirose1, K Wakabayashi, M Ochiai, H Kushida, H Sato, T Sugimura, M Nagao.   

Abstract

Effects of chronic administration of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) at 0.4, 8 and 400 ppm in the diet on DNA adduct formation and removal in the rat liver were examined by the 32P-postlabeling method. The 0.4 and 8 ppm doses for 40 weeks resulted in time-dependent increases in MeIQx-DNA adduct levels until 16 and 8 weeks, respectively, with constant values being maintained thereafter. In the case of a carcinogenic dose (400 ppm) of MeIQx, the adduct levels reached a maximum at week 12, and then gradually decreased. Alteration of metabolism of MeIQx during liver carcinogensis might be related to this decrease in DNA adduct levels. When MeIQx administration was stopped at week 20, 60-90% of the MeIQx-DNA adducts formed with the three doses (0.4, 8 and 400 ppm) of MeIQx were removed in a biphasic manner after return to a basal diet, with initial rapid removal followed by a slow change. No difference in the pattern of MeIQx-DNA adducts was detected on thin layer chromatography at any dose at any time point. Thus, it is suggested that there may be at least two types of damaged DNA, susceptible and resistant to removal of MeIQx-DNA adducts, after chronic administration of MeIQx.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622414      PMCID: PMC5920865          DOI: 10.1111/j.1349-7006.1995.tb02428.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  26 in total

1.  Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.

Authors:  T Kato; H Ohgaki; H Hasegawa; S Sato; S Takayama; T Sugimura
Journal:  Carcinogenesis       Date:  1988-01       Impact factor: 4.944

2.  Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.

Authors:  M V Reddy; K Randerath
Journal:  Carcinogenesis       Date:  1986-09       Impact factor: 4.944

3.  Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.

Authors:  R C Gupta
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

4.  Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver.

Authors:  A Buchmann; W Kuhlmann; M Schwarz; W Kunz; C R Wolf; E Moll; T Friedberg; F Oesch
Journal:  Carcinogenesis       Date:  1985-04       Impact factor: 4.944

5.  Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo.

Authors:  C D Davis; H A Schut; R H Adamson; U P Thorgeirsson; S S Thorgeirsson; E G Snyderwine
Journal:  Carcinogenesis       Date:  1993-01       Impact factor: 4.944

6.  Removal of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the male Fischer-344 rat.

Authors:  D A Cummings; H A Schut
Journal:  Carcinogenesis       Date:  1994-11       Impact factor: 4.944

7.  Effect of 3-methylcholanthrene induction on the distribution and DNA adduction of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in F344 rats.

Authors:  E G Snyderwine; K Nouso; H A Schut
Journal:  Food Chem Toxicol       Date:  1993-06       Impact factor: 6.023

8.  Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified cytochrome P-450.

Authors:  Y Yamazoe; M Abu-Zeid; S Manabe; S Toyama; R Kato
Journal:  Carcinogenesis       Date:  1988-01       Impact factor: 4.944

9.  DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration.

Authors:  K Yamashita; M Adachi; S Kato; H Nakagama; M Ochiai; K Wakabayashi; S Sato; M Nagao; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1990-05

10.  Exposure to heterocyclic amines.

Authors:  K Wakabayashi; H Ushiyama; M Takahashi; H Nukaya; S B Kim; M Hirose; M Ochiai; T Sugimura; M Nagao
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

View more
  3 in total

Review 1.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

2.  Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats.

Authors:  Ken-ichi Fujita; Takamasa Ohnishi; Kazunori Sekine; Masaaki Iigo; Hiroyuki Tsuda
Journal:  Jpn J Cancer Res       Date:  2002-06

3.  Dose-dependent induction of 8-hydroxyguanine and preneoplastic foci in rat liver by a food-derived carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, at low dose levels.

Authors:  T Kato; R Hasegawa; D Nakae; M Hirose; M Yaono; L Cui; Y Kobayashi; Y Konishi; N Ito; T Shirai
Journal:  Jpn J Cancer Res       Date:  1996-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.